Effects of crude extracts from medicinal herbs Rhazya stricta and Zingiber officinale on growth and proliferation of human brain cancer cell line in vitro

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Elkady, Ayman I ^a,b   Hussein, Rania Abd El Hamid ^a,c   Abu Zinadah, Osama A ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b Alexandria University Faculty Of Science   (Egypt)

^c Gamal Abd El Nasser Hospital   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; CYCLIN D1; CYTOCHROME C; GINGER EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN NOXA; PROTEIN P21; PROTEIN P53; RHAZYA STRICTA EXTRACT; SURVIVIN; ANTINEOPLASTIC AGENT; PLANT EXTRACT; TUMOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BREAST CANCER CELL LINE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; COLONY FORMATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME ACTIVITY; FREE RADICAL SCAVENGING ASSAY; HERB; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; APOCYNACEAE; APOPTOSIS; BRAIN NEOPLASMS; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GINGER; HELA CELL LINE; MEDICINAL PLANT; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOCYNACEAE; APOPTOSIS; BRAIN NEOPLASMS; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GINGER; HELA CELLS; HUMANS; NEOPLASM PROTEINS; PLANT EXTRACTS; PLANTS, MEDICINAL;

EID: 84929051796     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/260210     Document Type: Article

References (61)

1. M. Preusser, S. de Ribaupierre, A. Wohrer et al., "Current concepts and management of glioblastoma, " Annals of Neurology, vol. 70, no. 1, pp. 9-21, 2011.
2. C. Krakstad and M. Chekenya, "Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics, " Molecular Cancer, vol. 9, article 135, 2010.
3. Y. Cui, Q. Wang, J. Wang et al., "Knockdown of AKT2 expression by RNAinterference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to the anticancer drug VM-26 in U87 glioma cells, " Brain Research, vol. 1469, pp. 1-9, 2012.
4. R. S. Y. Wong, "Apoptosis in cancer: frompathogenesis to treatment, " Journal of Experimental and Clinical Cancer Research, vol. 30, no. 1, article 87, 2011.
5. W. C. Earnshaw, L. M. Martins, and S. H. Kaufmann, "Mammalian caspases: structure, activation, substrates, and functions during apoptosis, " Annual Review of Biochemistry, vol. 68, pp. 383-424, 1999.
6. A. Sarastea and K. Pulkki, "Morphologic and biochemical hallmarks of apoptosis, " Cardiovascular Research, vol. 45, pp. 528-537, 2000.
7. B. B. Aggarwal, M. E. Van Kuiken, L. H. Iyer, K. B. Harikumar, and B. Sung, "Molecular targets of nutraceuticals derived from dietary spices: potential role in suppression of inflammation and tumorigenesis, " Experimental Biology and Medicine, vol. 234, no. 8, pp. 825-849, 2009.
8. R. H. Liu, "Potential synergy of phytochemicals in cancer prevention:mechanismof action, " Journal of Nutrition, vol. 134, supplement 12, pp. 3479S-3485S, 2004.
9. L. A. Loeb, K. R. Loeb, and J. P. Anderson, "Multiplemutations and cancer, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 3, pp. 776-781, 2003.
10. C. J. Torrance, P. E. Jackson, E. Montgomery et al., "Combinatorial chemoprevention of intestinal neoplasia, " Nature Medicine, vol. 6, no. 9, pp. 1024-1028, 2000.
11. S. A. Gilani, A. Kikuchi, Z. K. Shinwari, Z. I. Khattak, and K. N. Watanabe, "Phytochemical, pharmacological and ethnobotanical studies of Rhazya stricta decne, " Phytotherapy Research, vol. 21, no. 4, pp. 301-307, 2007.
12. S. K. Marwat, K. Fazal-ur-Rehman, S. S. Shah, N. Anwar, and I. Ullah, "A review of phytochemistry, bioactivities and ethnomedicinal uses of Rhazya stricta Decsne (Apocynaceae), " African Journal ofMicrobiology Research, vol. 6, no. 8, pp. 1629-1641, 2012.
13. S. Iqbal, M. I. Bhanger, M. Akhtar, F. Anwar, K. R. Ahmed, and T. Anwer, "Antioxidant properties of methanolic extracts from leaves of Rhazya stricta, " Journal ofMedicinal Food, vol. 9, no. 2, pp. 270-275, 2006.
14. M. Huang, H. Gao, Y. Chen et al., "Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo, " Clinical Cancer Research, vol. 13, no. 4, pp. 1298-1307, 2007.
15. J. Lu, J. L. Bao, X. P. Chen, M. Huang, and Y. Wang, "Alkaloids isolated from natural herbs as the anticancer agents, " Evidencebased Complementary and Alternative Medicine, vol. 2012, Article ID 485042, 12 pages, 2012.
16. W. Li, Y. Shao, L. Hu et al., "BM6, a new semi-synthetic Vinca alkaloid, exhibits its potent in vivo anti-tumor activities via its high binding affinity for tubulin and improved pharmacokinetic profiles, " Cancer Biology and Therapy, vol. 6, no. 5, pp. 787-794, 2007.
17. R. Verpoorte, "Antimicrobially active alkaloids, " in Alkaloids: Biochemistry, Ecology andMedicinal Applications, M. F. Roberts and M. Wink, Eds., pp. 397-433, Plenum Press, New York, NY, USA, 1998.
18. S. Mukhopadhyay, G. A. Handy, S. Funayama, and G. A. Cordell, "Anticancer indole alkaloids of Rhazya stricta, " Journal of Natural Products, vol. 44, no. 6, pp. 696-700, 1981.
19. A. I. Elkady, "Crude alkaloid extract of Rhazya stricta inhibits cell growth and sensitizes human lung cancer cells to cisplatin through induction of apoptosis, " Genetics and Molecular Biology, vol. 36, no. 1, pp. 12-21, 2013.
20. M. A. M. El Gendy, B. H. Ali, K. Michail, A. G. Siraki, and A. O. S. El-Kadi, "Induction of quinone oxidoreductase 1 enzyme by Rhazya stricta through Nrf2-dependentmechanism, " Journal of Ethnopharmacology, vol. 144, no. 2, pp. 416-424, 2012.
21. M. S. Baliga, R. Haniadka, M. M. Pereira et al., "Update on the chemopreventive effects of ginger and its phytochemicals, " Critical Reviews in Food Science and Nutrition, vol. 51, no. 6, pp. 499-523, 2011.
22. H.-Y. Weng, M.-J. Hsu, C.-C. Wang et al., "Zerumbone suppresses IKKα, Akt, andFOXO1 activation, resulting in apoptosis of GBM 8401 cells, " Journal of Biomedical Science, vol. 19, no. 1, article 86, 2012.
23. M. K. Chahar, N. Sharma, M. P. Dobhal, and Y. C. Joshi, "Flavonoids: a versatile source of anticancer drugs, " Pharmacognosy Reviews, vol. 5, no. 9, pp. 1-12, 2011.
24. S. Ramos, "Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention, " Journal of Nutritional Biochemistry, vol. 18, no. 7, pp. 427-442, 2007.
25. A. Kale, S. Gawande, and S. Kotwal, "Cancer phytotherapeutics: role for flavonoids at the cellular level, " Phytotherapy Research, vol. 22, no. 5, pp. 567-577, 2008.
26. G. E. Trease and W. C. Evans, Pharmcognosy, Saunder Elsevier, London, UK, 16th edition, 2002.
27. A. I. Elkady, "Crude extract of Nigella sativa inhibits proliferation and induces apoptosis in human cervical carcinoma HeLa cells, " African Journal of Biotechnology, vol. 11, no. 64, pp. 12710-12720, 2012.
28. A. El-Kady, Y. Sun, Y. Li, and D. Liao, "Cyclin D1 inhibits whereas c-Myc enhances the cytotoxicity of cisplatin in mouse pancreatic cancer cells via regulation of several members of the NF-κB and Bcl-2 families, " Journal of Carcinogenesis, vol. 10, article 24, 2011.
29. K. R. Martin, "Targeting apoptosis with dietary bioactive agents, " Experimental Biology and Medicine, vol. 231, no. 2, pp. 117-129, 2006.
30. S. Nagata, "Apoptotic DNA fragmentation, " Experimental Cell Research, vol. 256, no. 1, pp. 12-18, 2000.
31. A. R. Collins, "Comet assay: principles, applications, and limitations, "Methods inMolecular Biology, vol. 203, pp. 163-177, 2002.
32. B. Raychaudhuri, Y. Han, T. Lu, and M. A. Vogelbaum, "Aberrant constitutive activation of nuclear factor κB in glioblastoma multiforme drives invasive phenotype, " Journal of Neuro-Oncology, vol. 85, no. 1, pp. 39-47, 2007.
33. L. Nogueira, P. Ruiz-Ontanon, A. Vazquez-Barquero, F. Moris, and J. L. Fernandez-Luna, "The NFκB pathway: a therapeutic target in glioblastoma, " Oncotarget, vol. 2, no. 8, pp. 646-653, 2011.
34. O. Laptenko and C. Prives, "Transcriptional regulation by p53: one protein, many possibilities, " Cell Death and Differentiation, vol. 13, no. 6, pp. 951-961, 2006.
35. A. I. Elkady, O. A. Abuzinadah, N. A. Baeshen, and T. R. Rahmy, "Differential control of growth, apoptotic activity, and gene expression in human breast cancer cells by extracts derived from medicinal herbs Zingiber officinale, " Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 614356, 14 pages, 2012.
36. N. A. Baeshen, A. I. Elkady, O. A. Abuzinadah, and M. H. Mutwakil, "Potential anticancer activity of the medicinal herb, Rhazya stricta, against human breast cancer, " African Journal of Biotechnology, vol. 11, no. 37, pp. 8960-8972, 2012.
37. M. S. Pavlyukov, N. V. Antipova, M. V. Balashova, T. V. Vinogradova, E. P. Kopantzev, and M. I. Shakhparonov, "Survivin monomer plays an essential role in apoptosis regulation, " Journal of Biological Chemistry, vol. 286, no. 26, pp. 23296-23307, 2011.
38. S. Yasuhara, Y. Zhu, T. Matsui et al., "Comparison of comet assay, electron microscopy, and flow cytometry for detection of apoptosis, " Journal of Histochemistry and Cytochemistry, vol. 51, no. 7, pp. 873-885, 2003.
39. H. Strik, M. Deininger, J. Streffer et al., "BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy, " Journal of Neurology Neurosurgery and Psychiatry, vol. 67, no. 6, pp. 763-768, 1999.
40. W. Wick, S. Wagner, S. Kerkau, J. Dichgans, J. C. Tonn, and M. Weller, "BCL-2 promotes migration and invasiveness of human glioma cells, " FEBS Letters, vol. 440, no. 3, pp. 419-424, 1998.
41. M. A. Vogelbaum, J. X. Tong, R. Perugu, D. H. Gutmann, and K. M. Rich, "Overexpression of bax in human glioma cell lines, " Journal of Neurosurgery, vol. 91, no. 3, pp. 483-489, 1999.
42. J. R. Streffer, A. Rimner, J. Rieger, U. Naumann, H. P. Rodemann, and M. Weller, "BCL-2 family proteins modulate radiosensitivity in human malignant glioma cells, " Journal of Neuro-Oncology, vol. 56, no. 1, pp. 43-49, 2002.
43. Y. Fan, R. Mao, Y. Zhao et al., "Tumor necrosis factor-α induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-κB activation, "The Journal of Biological Chemistry, vol. 284, no. 43, pp. 29290-29297, 2009.
44. I. Murtaza, V. M. Adhami, B. B. Hafeez, M. Saleem, and H. Mukhtar, "Fisetin, a natural flavonoid, targets chemoresistant human pancreatic cancer AsPC-1 cells through DR3-mediated inhibition of NF-κB, " International Journal of Cancer, vol. 125, no. 10, pp. 2465-2473, 2009.
45. S. Shukla and S. Gupta, "Suppression of constitutive and tumor necrosis factor α-induced nuclear factor (NF)-κB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-κB-responsive genes, " Clinical Cancer Research, vol. 10, no. 9, pp. 3169-3178, 2004.
46. G. Sethi, B. Sung, and B. B. Aggarwal, "Nuclear factor-κB activation: from bench to bedside, " Experimental Biology and Medicine, vol. 233, no. 1, pp. 21-31, 2008.
47. H. Zhen, X. Zhang, P. Hu et al., "Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas, " Cancer, vol. 105, no. 12, pp. 2775-2783, 2005.
48. A. C. Mita, M. M. Mita, S. T. Nawrocki, and F. J. Giles, "Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics, " Clinical Cancer Research, vol. 14, no. 16, pp. 5000-5005, 2008.
49. H. Uchida, T. Tanaka, K. Sasaki et al., "Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo, " Molecular Therapy, vol. 10, no. 1, pp. 162-171, 2004.
50. J. George, N. L. Banik, and S. K. Ray, "Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo, " Neuro-Oncology, vol. 12, no. 11, pp. 1088-1101, 2010.
51. S. V. Ekholm and S. I. Reed, "Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle, " Current Opinion in Cell Biology, vol. 12, no. 6, pp. 676-684, 2000.
52. C. A. Brady and L. D. Attardi, "p53 at a glance, " Journal of Cell Science, vol. 123, no. 15, pp. 2527-2532, 2010.
53. O. Bogler, H. J. Huang, P. Kleihues, and W. K. Cavenee, "The p53 gene and its role in human brain tumors, " Glia, vol. 15, no. 3, pp. 308-327, 1995.
54. E. W. Newcomb, W. J. Madonia, S. Pisharody, F. F. Lang, M. Koslow, and D. C. Miller, "A correlative study of p53 protein alteration and p53 gene mutation in glioblastoma multiforme, " Brain Pathology, vol. 3, no. 3, pp. 229-235, 1993.
55. B. Berger, D. Capper, D. Lemke et al., "Defective p53 antiangiogenic signaling in glioblastoma, " Neuro-Oncology, vol. 12, no. 9, pp. 894-907, 2010.
56. A. M. Abukhdeir and B. H. Park, "p21 and p27: roles in carcinogenesis and drug resistance, " Expert Reviews in Molecular Medicine, vol. 10, no. 19, 2008.
57. E. Oda, R. Ohki, H. Murasawa et al., "Noxa, a BH3-onlymember of the Bcl-2 family and candidate mediator of p53-induced apoptosis, " Science, vol. 288, no. 5468, pp. 1053-1058, 2000.
58. J. L. Armstrong, G. J. Veal, C. P. F. Redfern, and P. E. Lovat, "Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours, " Apoptosis, vol. 12, no. 3, pp. 613-622, 2007.
59. V. Labi, F. Grespi, F. Baumgartner, and A. Villunger, "Targeting the Bcl-2-regulated apoptosis pathway by BH3 mimetics: a breakthrough in anticancer therapy?" Cell Death and Differentiation, vol. 15, no. 6, pp. 977-987, 2008.
60. K. E. Tagscherer, A. Fassl, B. Campos et al., "Apoptosisbased treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins, " Oncogene, vol. 27, no. 52, pp. 6646-6656, 2008.
61. C. Ploner, R. Kofler, and A. Villunger, "Noxa: at the tip of the balance between life and death, " Oncogene, vol. 27, no. 1, pp. S84-S92, 2009.